AIM-listed DeepMatter (LON: DMTR) revealed it will be collaborating with the University of Nottingham’s School of Chemistry, providing access to the DigitalGlassware platform to support its sustainable chemistry initiatives.
The collaboration will be focused on developing machine learning models of sustainable chemistry for researchers in the pharmaceutical sector and related chemical-based industries.
The project, which will be lead by Professor Jonathan Hirst, will see scientists use DigitalGlassware, an integrated software, hardware and artificial intelligence platform, to develop machine learning techniques to help chemical engineers and chemists make their manufacturing processes more sustainable.
Professor Hirst will also work with scientists at the University of Nottingham's Centre for Sustainable Chemistry to build interactive machine learning models of sustainability that can be used in the early discovery phase by researchers in the pharmaceutical sector when developing new drugs and chemicals more sustainably.
“We recognise that significant changes are required in the way science is organised and conducted for there to be progress towards a more sustainable environment and we are pleased that our technology will play a role in developing the industry's sustainability,” said Mark Warne, CEO of DeepMatter.
DeepMatter’s share price is currently trading 5.87% higher on Wednesday at 2.49p.
Should you invest in DeepMatter shares?
Omega Diagnostics shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are Omega shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies